93 related articles for article (PubMed ID: 5708248)
1. Investigations on steroids. IX. Pharmacological studies. (3). Myotrophic and androgenic activities of 17beta-hydroxy-5alpha-androstano-[2,3-c]furazan and its derivatives.
Kasahara A; Onodera T; Oshima Y; Shimizu M
Chem Pharm Bull (Tokyo); 1968 Aug; 16(8):1456-9. PubMed ID: 5708248
[No Abstract] [Full Text] [Related]
2. Synthesis and myotrophic-androgenic activity of 17beta-hydroxy-5alpha-androst-8(14)-en-3-one derivatives.
Wolff ME; Chang HH
J Med Chem; 1970 Sep; 13(5):967-8. PubMed ID: 5458391
[No Abstract] [Full Text] [Related]
3. Synthesis and myotrophic-androgenic activity of substituted 2-alpha, 3-alpha-methano-5-alpha-androstane derivatives.
Wolff ME; Cheng SY; Ho W
J Med Chem; 1968 Jul; 11(4):864-8. PubMed ID: 5671257
[No Abstract] [Full Text] [Related]
4. Synthesis and anabolic/androgenic evaluation of novel 9alpha-fluorosteroids.
Reyes-Moreno M; Ruiz-García JA; Ibarra-Reyes Y; Fuente-Hernández A; Vélez-Castro H; Hernández-Balmaseda I; Martínez-Hormaza I; Rodeiro-Guerra I; Ramírez JS; Reyes SM; Montiel-Smith S
Eur J Med Chem; 2009 Nov; 44(11):4567-71. PubMed ID: 19615789
[TBL] [Abstract][Full Text] [Related]
5. The effects of 5alpha-reduced androgens on maintenance and regeneration of prostate glands and seminal vesicles in castrated and hypophysectomized rats.
Ahmad N; Warren DW; Haltmeyer GC
Anat Rec; 1978 Dec; 192(4):543-54. PubMed ID: 736274
[TBL] [Abstract][Full Text] [Related]
6. Comparative androgenic, myotrophic and antigonadotrophic properties of some anabolic steroids.
Boris A; Stevenson RH; Trmal T
Steroids; 1970 Jan; 15(1):61-71. PubMed ID: 5410669
[No Abstract] [Full Text] [Related]
7. Prodrugs utilizing organosilyl derivation: an investigation of the long-term androgenic and myotrophic activities of silyl derivatives of testosterone.
Millership JS; Shanks ML
J Pharm Sci; 1988 Feb; 77(2):116-9. PubMed ID: 3361425
[TBL] [Abstract][Full Text] [Related]
8. Some aspects of the relation between chemical structure of steroids and their prostatotropic effect in rats.
de Visser J
Acta Physiol Pharmacol Neerl; 1967 Dec; 14(4):527-8. PubMed ID: 5582730
[No Abstract] [Full Text] [Related]
9. Investigations on steroids. X. Pharmacological studies. (4). Conversion of 17 beta-hydroxy-5alpha-androstano[2,3-c]furazan into 17-oxo compound by rat liver in vitro.
Kasahara A
Chem Pharm Bull (Tokyo); 1968 Aug; 16(8):1460-5. PubMed ID: 5708249
[No Abstract] [Full Text] [Related]
10. New classes of orally active hormonal derivatives. II. 17-Cycloalk-1'-enyl ethers of 17 -hydroxy-androstanes and 19-norandrostanes.
Gardi R; Falconi G; Pedrali C; Vitali R; Ercoli A
Steroids; 1972 May; 19(5):639-47. PubMed ID: 5041787
[No Abstract] [Full Text] [Related]
11. Effect of steroids with antiandrogenic properties on androgenic and myotrophic activity of testosterone and some of its derivatives.
Ivanenko TI
Neurosci Behav Physiol; 1980; 10(3):227-31. PubMed ID: 7413078
[No Abstract] [Full Text] [Related]
12. [Effect of steroids with anti-androgenic properties on the androgenic and myotrophic activity of testosterone and its various derivatives].
Ivanenko TI
Probl Endokrinol (Mosk); 1978; 24(4):86-91. PubMed ID: 683979
[TBL] [Abstract][Full Text] [Related]
13. New classes of orally active hormonal derivatives. 1. Alkyl androstan-17beta-YL and alkyl 19-norandrostan-17beta-YL mixed acetals.
Vitali R; Gardi R; Falconi G; Ercoli A
Steroids; 1966 Oct; 8(4):527-36. PubMed ID: 5972513
[No Abstract] [Full Text] [Related]
14. The causes of the prolonged action of 5-alpha-androst-2-EN-17-beta-OL.
Cekan Z; Bartosek I
Steroids; 1967 Jul; 10(1):75-81. PubMed ID: 6059114
[No Abstract] [Full Text] [Related]
15. Heterocyclic steroids. 4. Synthesis and androgenic activity of A-ring homosteroids.
Zanati G; Wolff ME
J Med Chem; 1972 Apr; 15(4):368-9. PubMed ID: 5019551
[No Abstract] [Full Text] [Related]
16. Effect of 1-alkyl substitution on the biological action in a series of androstanes.
Cekan Z; Pelc B
Steroids; 1966 Aug; 8(2):209-18. PubMed ID: 5978620
[No Abstract] [Full Text] [Related]
17. Effects of 5alpha-reduced androgens on preputial-gland size and lipogenic activity.
Bowden PE; Meddis D; Cooper MF; Thody AJ; Shuster S
Biochem Soc Trans; 1976; 4(4):795-7. PubMed ID: 1001770
[No Abstract] [Full Text] [Related]
18. Anabolic-androgenic activity of A-ring modified androstane derivatives. II. A comparison of oral activity.
Nutting EF; Klimstra PD; Counsell RE
Acta Endocrinol (Copenh); 1966 Dec; 53(4):635-43. PubMed ID: 5953689
[No Abstract] [Full Text] [Related]
19. A new antiandrogen, 6alpha-bromo-17 beta-hydroxy-17 alpha-methyl-4-oxa-5 alpha-androstan-3-one.
Boris A; Uskoković M
Experientia; 1970 Jan; 26(1):9-10. PubMed ID: 5412314
[No Abstract] [Full Text] [Related]
20. Cycloprop(16 ,17 )androstanes.
Fahrenholtz KE; Meyes KP; Kierstead RW
J Med Chem; 1972 Oct; 15(10):1056-60. PubMed ID: 5069774
[No Abstract] [Full Text] [Related]
[Next] [New Search]